Skip to main content

Table 1 Study participant characteristics

From: Development and pilot testing of a decision aid for navigating breast cancer survivorship care

Characteristic

Round 1

Round 2

Round 3

Breast cancer survivors

n = 5

n = 5

n = 5

Age, median (range)

51 (46–54)

49 (47–64)

60 (47–67)

Race, n (%)

 Chinese

4 (80%)

4 (80%)

3 (60%)

 Malay

1 (20%)

0

2 (40%)

 Others

0

1a (20%)

0

Education level, n (%)

 Secondary

1 (20%)

1 (20%)

1 (20%)

 Pre-university

1 (20%)

1 (20%)

2 (40%)

 Graduate/postgraduate

3 (60%)

3 (60%)

2 (40%)

 Survivorship years since diagnosis, median (range)

9 (8–12)

8 (8–10)

7 (10–13)

Breast cancer stageb, n (%)

 1

1 (20%)

3 (60%)

1 (20%)

 2

2 (40%)

2 (40%)

2 (40%)

 3

1 (20%)

0

2 (40%)

Treatment modality, n (%)

 Surgery

5 (100%)

5 (100%)

5 (100%)

 Chemotherapy

5 (100%)

5 (100%)

4 (80%)

 Radiotherapy

5 (100%)

3 (60%)

4 (80%)

 Endocrine therapy

3 (60%)

3 (60%)

3 (60%)

Health care professionals

n = 3

n = 3

n = 2

Discipline, n (%)

 Medical oncology

2 (67%)

0

1 (50%)

 Radiation oncology

0

1 (33%)

0

 Surgical oncology

0

2 (67%)

0

 Nursing

0

0

1 (50%)

 Pharmacy

1 (33.3%)

0

0

Years of practice, n (%)

 10–20 years

2 (67%)

3 (100%)

2 (100%)

 > 20 years

1 (33%)

0

0

  1. aBurmese
  2. bOne participant from round 1 could not recall her breast cancer stage